Sionna Therapeutics Statistics
Total Valuation
SION has a market cap or net worth of $273.99 million. The enterprise value is $13.80 million.
| Market Cap | 273.99M |
| Enterprise Value | 13.80M |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SION has 45.21 million shares outstanding. The number of shares has increased by 124.56% in one year.
| Current Share Class | 45.21M |
| Shares Outstanding | 45.21M |
| Shares Change (YoY) | +124.56% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 51.17% |
| Float | 17.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.03 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.05, with a Debt / Equity ratio of 0.03.
| Current Ratio | 20.05 |
| Quick Ratio | 19.57 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.34% and return on invested capital (ROIC) is -22.09%.
| Return on Equity (ROE) | -32.34% |
| Return on Assets (ROA) | -21.54% |
| Return on Invested Capital (ROIC) | -22.09% |
| Return on Capital Employed (ROCE) | -40.18% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.65M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -75.97% |
| 50-Day Moving Average | 33.73 |
| 200-Day Moving Average | 38.05 |
| Relative Strength Index (RSI) | 23.68 |
| Average Volume (20 Days) | 4,494,997 |
Short Selling Information
The latest short interest is 4.25 million, so 9.40% of the outstanding shares have been sold short.
| Short Interest | 4.25M |
| Short Previous Month | 4.20M |
| Short % of Shares Out | 9.40% |
| Short % of Float | 24.95% |
| Short Ratio (days to cover) | 7.54 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -109.49M |
| Pretax Income | -97.38M |
| Net Income | -97.38M |
| EBITDA | -108.84M |
| EBIT | -109.49M |
| Earnings Per Share (EPS) | -$2.17 |
Balance Sheet
The company has $211.03 million in cash and $8.07 million in debt, with a net cash position of $260.18 million or $5.75 per share.
| Cash & Cash Equivalents | 211.03M |
| Total Debt | 8.07M |
| Net Cash | 260.18M |
| Net Cash Per Share | $5.75 |
| Equity (Book Value) | 265.78M |
| Book Value Per Share | 5.88 |
| Working Capital | 205.35M |
Cash Flow
In the last 12 months, operating cash flow was -$75.92 million and capital expenditures -$291,000, giving a free cash flow of -$76.21 million.
| Operating Cash Flow | -75.92M |
| Capital Expenditures | -291,000 |
| Depreciation & Amortization | 650,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -76.21M |
| FCF Per Share | -$1.69 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SION does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -124.56% |
| Shareholder Yield | -124.56% |
| Earnings Yield | -35.54% |
| FCF Yield | -27.81% |
Analyst Forecast
The average price target for SION is $15.17, which is 150.33% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.17 |
| Price Target Difference | 150.33% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |